At3g25210 Antibody

Shipped with Ice Packs
In Stock

Description

Biological Target: AT3G25210 Protein

The AT3G25210 gene encodes a TPR-like superfamily protein, which typically mediates protein-protein interactions in cellular processes such as stress responses, hormone signaling, and chloroplast function . TPR domains are known to form scaffold structures that facilitate multi-protein complex assembly.

Functional Insights from Homologous Systems

Research on related TPR-containing proteins in Arabidopsis provides context for AT3G25210’s potential roles:

  • Stress Adaptation: TPR proteins regulate responses to abiotic stressors (e.g., drought, salinity) .

  • Chloroplast Function: Some TPR proteins assist in chloroplast RNA editing or protein import .

  • Hormone Signaling: Interactions with jasmonic acid or ethylene pathways have been observed in structurally similar proteins .

Technical Considerations

  • Cross-Reactivity: Antibodies against plant proteins often require rigorous validation due to high sequence homology across paralogs.

  • Epitope Stability: TPR domains may adopt variable conformations; antibody performance can depend on antigen presentation .

Future Research Directions

Key unanswered questions include:

  • Subcellular Localization: Does AT3G25210 localize to organelles like chloroplasts or mitochondria?

  • Phenotypic Impact: What developmental defects arise in AT3G25210 knockout mutants?

  • Disease Relevance: Is this protein involved in pathogen response pathways?

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
At3g25210 antibody; MJL12.16 antibody; Pentatricopeptide repeat-containing protein At3g25210 antibody; mitochondrial antibody
Target Names
At3g25210
Uniprot No.

Target Background

Database Links

KEGG: ath:AT3G25210

STRING: 3702.AT3G25210.1

UniGene: At.37406

Protein Families
PPR family, P subfamily
Subcellular Location
Mitochondrion.

Q&A

What are the primary applications for At3g25210 antibodies in plant research?

At3g25210 antibodies are primarily used for detecting and studying the corresponding protein in Arabidopsis thaliana. Methodologically, these antibodies can be employed in multiple experimental techniques including Western blotting, immunoprecipitation, immunofluorescence microscopy, flow cytometry, and chromatin immunoprecipitation (ChIP). When designing experiments, researchers should consider that different applications require different antibody properties - for instance, native protein detection versus denatured protein detection requires antibodies with different epitope recognition properties . For immunohistochemistry, tissue preparation methods significantly affect antibody binding, so optimization is essential for each specific application.

How should I validate the specificity of an At3g25210 antibody before using it in critical experiments?

Proper antibody validation is crucial for experimental reliability. A methodological approach to validation should include:

  • Western blot analysis using positive controls (wild-type plant tissue) and negative controls (knockout mutants lacking At3g25210 expression)

  • Immunoprecipitation followed by mass spectrometry to confirm target binding

  • Testing on tissue samples with known expression patterns

  • Competitive binding assays with the purified antigen

  • Cross-reactivity testing against closely related proteins

As demonstrated in monoclonal antibody research, target binding specificity can be significantly affected by minor genetic variations, as seen with mAb 2A2 which showed variable efficacy against different parasite strains due to amino acid mutations affecting antibody binding . Therefore, thorough validation against potential cross-reactive targets is essential for ensuring experimental reliability.

What considerations should guide my selection between monoclonal and polyclonal At3g25210 antibodies?

The choice between monoclonal and polyclonal antibodies should be guided by experimental requirements:

Monoclonal antibodies:

  • Provide high specificity for a single epitope, reducing background noise

  • Offer consistent lot-to-lot reproducibility

  • Better for distinguishing between closely related proteins

  • May be less effective if the target epitope is altered by processing or mutations

Polyclonal antibodies:

  • Recognize multiple epitopes, potentially increasing detection sensitivity

  • More tolerant to minor changes in protein structure or modifications

  • Often more effective for precipitation applications

  • May show greater batch variation

Research with mAb 45.1 demonstrates how monoclonal antibodies can maintain efficacy across genetically diverse targets by binding highly conserved epitopes . Conversely, as shown with mAb 2A2, monoclonal antibodies targeting less conserved regions may fail against variants with mutations in the binding domain .

How can I address epitope masking issues when At3g25210 exists in protein complexes?

Epitope masking occurs when the antibody's target region is obscured by protein-protein interactions or conformational changes. To methodologically address this issue:

  • Use multiple antibodies targeting different epitopes of At3g25210

  • Employ gentle detergents to partially disrupt protein-protein interactions without denaturing the target

  • Consider crosslinking strategies to preserve transient interactions while allowing antibody access

  • Utilize proximity ligation assays (PLA) to detect proteins in close proximity

  • Implement epitope retrieval methods for fixed samples

As demonstrated in research with pan-amyloid binding antibodies, conformational epitopes can be crucial for antibody recognition . The 3H3 antibody recognizes a conformational epitope present in multiple amyloid structures despite different primary protein sequences . Similar principles apply when working with plant proteins that may present different conformational states or exist in complexes.

What methodological approaches can resolve conflicting results between At3g25210 antibody-based techniques and other detection methods?

When facing contradictory results between antibody-based detection and other methods (e.g., mass spectrometry, RNA-seq, or reporter constructs), implement this systematic approach:

  • Reassess antibody specificity using knockout/knockdown controls

  • Compare results across multiple antibodies targeting different epitopes

  • Evaluate potential post-translational modifications that might affect antibody recognition

  • Consider protein degradation or processing that might remove the epitope

  • Examine spatiotemporal expression patterns that might explain discrepancies

  • Implement orthogonal detection methods to triangulate true expression patterns

As observed in research with PRL-3 nanobodies, combining multiple detection techniques provides complementary information about protein localization and interactions . The ability of nanobodies to locate PRL-3 within cancer cells gave researchers new insights into protein-protein interactions that wouldn't be apparent with single-method approaches .

How can I optimize At3g25210 antibody performance for low-abundance target detection?

For detecting low-abundance At3g25210 protein:

  • Signal amplification strategies:

    • Implement tyramide signal amplification (TSA) for immunohistochemistry

    • Use high-sensitivity detection reagents (e.g., SuperSignal West Femto)

    • Consider biotin-streptavidin amplification systems

  • Sample enrichment approaches:

    • Perform subcellular fractionation to concentrate the target

    • Use immunoprecipitation to concentrate before detection

    • Consider protein extraction methods optimized for low-abundance proteins

  • Instrument optimization:

    • For flow cytometry, adjust PMT voltages appropriately for maximum sensitivity

    • Use confocal microscopy with optimized laser power and detection settings

    • For Western blotting, extend exposure times with low-noise detection systems

Lessons from nanobody research demonstrate how selective binding tools can significantly improve detection sensitivity for challenging targets . The small size of binding fragments can also improve tissue penetration and epitope accessibility for detection of proteins in complex environments.

What are the most effective methods to determine potential cross-reactivity of At3g25210 antibodies with related plant proteins?

Cross-reactivity assessment requires a multi-faceted approach:

  • Sequence analysis:

    • Identify proteins with sequence homology to At3g25210

    • Focus on regions containing the immunizing epitope

  • Experimental validation:

    • Test antibody reactivity against recombinant related proteins

    • Perform Western blots on tissues from plants lacking At3g25210 but expressing related proteins

    • Use peptide competition assays with related protein sequences

  • Advanced verification:

    • Use immunoprecipitation followed by mass spectrometry to identify all captured proteins

    • Test antibody on tissue arrays with known expression profiles of related proteins

Research with transmission-blocking antibodies demonstrates how sequence variations significantly impact binding efficacy, as seen with Pfs230 domain IV showing the highest density of SNPs and corresponding variations in antibody binding . Similar principles apply to plant antibodies, where even minor sequence variations in related proteins might enable or prevent antibody binding.

How can genetic diversity within plant species affect At3g25210 antibody binding and experimental reliability?

Genetic diversity impacts antibody reliability through:

  • Epitope variation:

    • Single nucleotide polymorphisms (SNPs) may alter amino acid sequences in epitope regions

    • Post-translational modifications might differ between ecotypes

    • Alternative splicing can remove or alter epitope regions

  • Methodological considerations:

    • Test antibodies against protein from multiple ecotypes or cultivars

    • Sequence the target gene in your specific plant material

    • Consider using multiple antibodies targeting different epitopes

    • Include appropriate genetic controls for each ecotype studied

The impact of genetic diversity is exemplified by mAb 2A2, which effectively blocked transmission in some parasite strains but failed in others due to mutations in domain IV of its target protein . Similarly, when working with plant proteins across different ecotypes or related species, researchers must verify antibody efficacy across the genetic variations present in their experimental system.

What flow cytometry parameters and controls are essential when using At3g25210 antibodies for intracellular staining?

For optimal flow cytometry with At3g25210 antibodies:

  • Essential controls:

    • Unstained cells to establish autofluorescence

    • Secondary antibody-only control to assess non-specific binding

    • Isotype control matched to primary antibody

    • Positive control (tissue known to express At3g25210)

    • Negative control (knockout/knockdown tissue)

  • Critical parameters:

    • Fixation and permeabilization conditions must be optimized for intracellular targets

    • Titrate antibody concentrations to determine optimal signal-to-noise ratio

    • Adjust compensation settings for multi-color experiments

    • Set appropriate FSC/SSC gates to exclude debris and select intact cells

  • Technical considerations:

    • Cell preparation methods significantly impact antibody accessibility

    • Buffer composition affects antibody binding and background signals

    • Staining time and temperature require optimization

Flow cytometry experimental design requires careful consideration of sample preparation, antibody concentration, and appropriate controls to ensure reliable data interpretation . When analyzing plant cells, additional considerations for cell wall digestion and autofluorescence management become crucial for successful experiments.

What methodological approaches can improve At3g25210 antibody performance in fixed plant tissues?

Optimizing antibody performance in fixed tissues requires:

  • Fixation optimization:

    • Test multiple fixatives (paraformaldehyde, glutaraldehyde, methanol)

    • Optimize fixation duration and temperature

    • Consider dual fixation approaches for different cellular components

  • Antigen retrieval methods:

    • Heat-induced epitope retrieval (HIER) with citrate or EDTA buffers

    • Enzymatic antigen retrieval with proteases

    • pH-adjusted retrieval solutions

  • Signal enhancement strategies:

    • Signal amplification systems (TSA, HRP-polymer)

    • Extended primary antibody incubation at lower temperatures

    • Detergent optimization for improved tissue penetration

  • Background reduction:

    • Pre-adsorption of antibodies with plant powder

    • Blocking with appropriate proteins (BSA, normal serum, casein)

    • Inclusion of detergents and salt in washing buffers

Research with diverse antibody applications shows that epitope accessibility is critically dependent on sample preparation techniques, particularly for conformational epitopes like those recognized by the 3H3 antibody in amyloid structures . Similarly, plant tissues require careful preparation to maintain both antigen integrity and accessibility.

What systematic approach should I take when At3g25210 antibody fails to detect its target in Western blots?

When facing Western blot detection failures:

  • Sample preparation assessment:

    • Verify protein extraction efficiency with other abundant proteins

    • Test different extraction buffers with varying detergent strengths

    • Evaluate protein degradation with freshly prepared samples

    • Consider enrichment of subcellular fractions

  • Technical parameters:

    • Optimize transfer conditions (time, buffer, membrane type)

    • Try reducing/non-reducing conditions

    • Adjust blocking reagents (milk vs. BSA)

    • Increase antibody concentration or incubation time

    • Test alternative detection systems

  • Antibody validation:

    • Confirm antibody activity with positive control samples

    • Test alternative antibodies targeting different epitopes

    • Consider whether post-translational modifications affect recognition

  • Protein characteristics:

    • Adjust gel percentage for appropriate molecular weight resolution

    • Consider special conditions for membrane proteins or highly basic proteins

Research with mAb 2A2 demonstrated that binding to native protein versus recombinant fragments can differ dramatically, highlighting the importance of protein conformation for antibody recognition . Similar considerations apply when optimizing Western blot conditions for plant proteins.

What methodological strategies can address variability in At3g25210 immunostaining results between experiments?

To reduce experimental variability:

  • Standardize protocols:

    • Document and strictly follow detailed protocols

    • Prepare master mixes for critical reagents

    • Process all experimental samples in parallel

  • Control implementation:

    • Include internal positive controls in every experiment

    • Use identical reference samples across experiments

    • Implement biological replicates from independent plant populations

  • Technical considerations:

    • Maintain consistent antibody lots when possible

    • Prepare fresh working solutions for each experiment

    • Control environmental factors (temperature, light exposure)

    • Standardize image acquisition parameters

  • Quantitative approaches:

    • Implement automated image analysis workflows

    • Use relative quantification against internal standards

    • Apply appropriate statistical tests for experimental variation

The importance of standardized protocols is evident in the development of transmission-blocking antibody assessments, where both standard membrane feeding assays (SMFA) and direct membrane feeding assays (DMFA) were carefully controlled to evaluate antibody efficacy across diverse parasite strains .

How can nanobody or single-chain antibody fragments be developed against At3g25210 for specialized applications?

Developing nanobodies against At3g25210 involves:

  • Generation approaches:

    • Immunization of camelids (alpacas, llamas) with purified At3g25210 protein

    • Construction and screening of synthetic or naive phage display libraries

    • Directed evolution of existing antibody fragments

  • Selection and screening:

    • Phage display selection against immobilized target

    • Cell-based screening for conformational epitopes

    • Competitive elution to identify high-affinity binders

  • Characterization and optimization:

    • Affinity measurements (SPR, BLI)

    • Epitope mapping

    • Stability enhancement through protein engineering

  • Application advantages:

    • Improved tissue penetration for in vivo imaging

    • Access to sterically restricted epitopes

    • Expression in plant systems as intrabodies for protein function modulation

Research with alpaca-derived nanobodies demonstrates their utility in targeting protein active sites and detecting proteins within cells with high specificity . The small size of nanobodies (approximately 15 kDa) provides advantages for accessing restricted epitopes and maintaining stability under various conditions, making them particularly valuable for challenging targets.

What considerations should guide the design of At3g25210 antibody conjugates for super-resolution microscopy?

For super-resolution microscopy applications:

  • Conjugation chemistry:

    • Site-specific conjugation to maintain antibody function

    • Optimal fluorophore-to-antibody ratio determination

    • Fluorophore selection based on photophysical properties (photostability, brightness)

  • Technical requirements:

    • Small label size for minimal linkage error

    • Monovalent binding fragments to improve localization precision

    • Direct labeling to reduce displacement error from secondary antibodies

  • Validation approaches:

    • Functional testing of conjugates compared to unconjugated antibodies

    • Resolution testing with known structures

    • Quantitative assessment of background and specificity

  • Application-specific optimizations:

    • STORM: Buffer systems containing oxygen scavengers and thiols

    • STED: Photostable dyes with appropriate stimulated emission profiles

    • DNA-PAINT: Oligonucleotide-conjugated antibodies with optimized binding kinetics

The principles of antibody binding specificity and affinity demonstrated in diverse research contexts remain crucial when developing specialized conjugates for advanced imaging techniques, where maintaining antibody recognition properties while adding detection functionality presents unique challenges.

What bioinformatic approaches can predict At3g25210 antibody epitopes and potential cross-reactivity?

Computational approaches for epitope prediction include:

  • Sequence-based analysis:

    • Antigenicity prediction algorithms (Kolaskar-Tongaonkar, BepiPred)

    • Hydrophilicity and surface accessibility calculations

    • Conservation analysis across related species

    • Structural disorder prediction for linear epitope identification

  • Structure-based methods:

    • Homology modeling of At3g25210 protein structure

    • Epitope mapping using molecular dynamics simulations

    • Molecular docking to predict antibody-antigen interactions

    • Electrostatic surface analysis for interaction hotspots

  • Cross-reactivity assessment:

    • BLAST searches against plant proteomes to identify similar sequences

    • Epitope conservation analysis across related proteins

    • Structural similarity searches beyond sequence homology

Analysis of domain conservation in malaria parasite proteins revealed that domain IV of Pfs230 was the most polymorphic region, explaining antibody binding variability across strains . Similar computational approaches can identify regions of plant proteins most likely to show variation and potentially affect antibody recognition.

How should quantitative data from At3g25210 antibody-based experiments be normalized and statistically analyzed?

Rigorous data analysis requires:

Research evaluating antibody efficacy across diverse parasite strains employed rigorous statistical analysis to determine IC80 values (concentration achieving 80% transmission-reducing activity), providing a quantitative measure of antibody potency . Similar quantitative approaches should be applied when evaluating plant antibody specificity and efficacy.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.